On the stock market since 2020, it operates in the world of health and science. It has 196 employees. Now — the numbers.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
This grade is a blend: the profit side is strong, the sales tempo slow.
The stock has been running stronger than the market lately.
Business Quality: Profit power and business quality trail similar companies in the sector.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
The stock trades 55% below its peak. The market has trimmed its expectations for the company.
Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.
This stock swings about 2.7 times as much as the market average. Big rallies — and big drops — can both happen fast.
Measured against its sector, the quality of the business sits below the class average. Report-card grade: 19/100.
Today’s price already includes part of tomorrow’s optimism. Report-card grade: 32/100.
On our five-subject report card, FDMT sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: FDMT is a high-risk stock — not yet profitable, and its future rides on its product catching on.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.